flow trial semaglutide renal outcomes 2024 Randomized clinical trials evaluating kidney of sodium-glucose FLOWing with the SemagluTIDE —

Essentially a copy is generally defined as identical or nearly identical to an FDA approved drug

The method-of-use patent covers the specific therapeutic indication, patient population, and dosing regimen as described in the FDA-approved label

doi:10.1007/s13300-018-0454-9.

Specifically, some people shed an average of five pounds (equivalent to 2.3 kilograms) while taking Rybelsus 7mg, and even more excellent results were observed with Rybelsus 14mg, where individuals lost an average of 8.1 pounds (approximately 3.7 kilograms)1

Uses Semaglutide is used to lower blood sugar levels in adults with type 2 diabetes mellitus

It is important to note that not all patients using Ozempic will experience this side effect